chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Exanthema, Chills, Myalgia, Pruritus - Information has been received from a physician concerning a 29 year old caucasian female patient who on 03 Apr 2000 was vaccinated with a first dose of varicella virus vaccine live sc in the left deltoid.  On approximately 19 Apr 2000, the patient developed a generalized chickenpox rash with greater than 20 lesions.  The patient sought unspecified medial attention.  Follow up information from a physician indicated that the patient also experienced chills, myalgias, and pruritis and had greater than 50 papules.  In addition the patient's laboratory results showed a varicella IgG 1.67 and varicella Igm 4. subsequently. the patient recovered.
After few seconds of getting vaccine, patient reported dizziness and lightheadedness. Lost consciousness for 5 seconds. Patient regained consciousness afterwards with sternum rub. Vital signs taken. Patient was placed on flat floor and legs were elevated. Patient stated history of passing out. Patient is now alert and oriented, and reported feeling better. Patient was offered with water and blanket. Monitored for another 30 minutes. Patient left in stable condition at 5:20pm, and advised to seek medical help if any further symptoms.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On 08-DEC-2015, the patient was vaccinated with improperly stored PNEUMOVAX (lot # L002310 exp date 08-JUL-2016) (dose and route not reported). The temperature and time of excursion was 1.11 degrees C for 208 hours. The vaccine status was reported as "in excursion", the storage criteria and the vaccine excursion were reported as "Refrigerator (R)". No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Approximately 10 days ago (12/6/21) the patient started having hives on his head.  He took a hot shower then noticed the rash and pruritus spread down to his body.  During that evening, he developed more itching and more hives.  In the morning he had swelling in his arms and face and diffuse hives.  He went to urgent care.  He was prescribed Benadryl every 6 hours and a short course of prednisone 40 mg daily.  The prednisone seemed to help.  The diphenhydramine may have helped slightly.  After finishing the short course of prednisone, his hives returned to where they previously were.  He has also tried applying oatmeal cream which has provided some symptom relief. He has not tried using second-generation antihistamine   He received the SARS-CoV-2 moderna vaccine booster on November 24 (approximately a week and a half prior to onset hives).  He did not have any immediate symptoms after receiving the vaccine.  He did feel significantly fatigued in the days following.  He denies any recent illnesses.  He denies any joint pain or joint swelling.   He has noticed no clear triggers of the hives including specific foods.  The hot shower certainly did make it worse, but is not required for him to develop hives.  He has not taken any NSAID medications.
This spontaneous prospective pregnancy report was received from a medical assistant concerning a 23 year old female patient. The patient did not have any concomitant medications, pertinent medical history or drug reactions/allergies. On 06-FEB-2017, the patient was vaccinated with VARIVAX (lot # M010483 with expiration date 03-MAR-2018) (dose, strength, frequency, route of administration and anatomical location were not provided), for varicella prevention. At the time of the vaccination, the patient was 25 weeks and 4 days pregnant. No adverse effects were reported. No treatment was given for the adverse events. The reporter stated that no tests for pregnancy were performed at the time of the vaccination. Also no other laboratory diagnostics studies were performed. The patient's last menstrual period was 11-AUG-2016 and estimated date of delivery was 18-MAY-2017. The pregnancy outcome was pending. Additional information has been requested.
Diagnosed at clinic as "covid arm"  Upper arm just below injection site was red, swollen and extremely warm/hot with small blisters (approximately 1 cm) which sometimes conjoined with neighbors blister.  Blisters contained clear liquid and forms  no discernible pattern.  Recovered by 2/17/2021
Light-headed; Fever of 100.4 F; Nausea; Fatigue; This is a spontaneous report from a contactable consumer. A 14-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: EW0187, Expiry date was not reported), via an unspecified route of administration on 08Jun2021 (Age at vaccination 14-year-old) as dose 2, single for covid-19 immunization. Medical history included allergic (rash) to penicillin and cephalosporin. The patients concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number, Expiry date was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization, cephalosporin c and experienced dermatitis allergic. The patient experienced fever of 100.4 Fahrenheit (F), light-headed, nausea, fatigue onset about 12 hours post dose on an unspecified date 2021. The patient underwent lab tests and procedures which included body temperature: 100.4 Fahrenheit on an unspecified date 2021. The clinical outcome of events was unknown.  No follow-up attempts are possible. No further information is expected.
nausea; vomiting; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 43 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 09May2021 09:30 (Lot number: EW0170) at the age of 43 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "alcohol, to slow her drinking" (ongoing), notes: alcohol, to slow down her drinking. Concomitant medication(s) included: BACLOFEN taken for alcoholism (ongoing). Vaccination history included: Bnt162b2 (Dose number: 1, Anatomical Location: Right Arm, Batch/lot number: EW0161), administration date: 18Apr2021, for covid-19 immunization, reaction(s): "soreness in arm after first dose". The following information was reported: NAUSEA (non-serious) with onset 11May2021 08:00, outcome "not recovered", described as "nausea"; VOMITING (non-serious) with onset 11May2021 08:00, outcome "not recovered", described as "vomiting".  Additional information: The reporter was asking could this be a side effect of the vaccine or the Baclofen. Baclofen: started 6-9 months ago, more towards 9 months. The dose changes every other week. They increase it. Each pill is 20 mg, and he thinks she is taking about 125 mg daily. The patient had not visited the Emergency Room or her Primary Medical Doctor, they thought it would go away by now. Nausea and throwing up started Tuesday, 11May2021, and it continues, it was worse. History of all previous immunization with the Pfizer vaccine considered as suspect was none. Additional Vaccines Administered on Same Date of the Pfizer Suspect was no.   No follow-up attempts are possible. No further information is expected.
Second Dose of Pfizer Covid vaccine.  At 3:20 pm started a rapid heartrate.  About 10 times before the rapid heartrate stopped, my heartrate would go back to normal for about 2 minutes then start up again.  At 6:10pm my heartrate became and stayed normal.  Did not seek professional medical attention.
Patient presented with chest pain .troponin peaked at 7.5. Patient discharged hospital with diagnosis of ?myocarditis secondary to  moderna vaccination?.
Dermatographia with rash/dermatographia symptoms beginning 10 days after booster dose.   Extremely itchy and persistent.
Patient told his mother that his right eye was burning within minutes of receiving the vaccines.  The eye became swollen shut and patient's mother took him to the emergency room. He was given Benadryl (2cc's,every 4 hours).
Redness, swelling, itching and warmth. Started on Claritin on 7/23/13.
Diarrhoea; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhoea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, the patient experienced DIARRHOEA (Diarrhoea). At the time of the report, DIARRHOEA (Diarrhoea) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore, the action taken with the drug in response to the events was not applicable.
This spontaneous report was received from a register nurse referring to a patient of unknown age and gender, whose concurrent conditions and medical history were not reported. On 29-NOV-2015 the patient was vaccinated with his/her first dose of MMR II (route, anatomical site of vaccination, lot number and expiration date were not provided) indicated, later on 19-DEC-2015, the patient received his/her second dose of MMR II (route, anatomical site of vaccination, lot number and expiration date were not provided). It was reported that "the doses were given too close together; they were not 28 days apart". No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
Vail was expired on 29Apr2022 and Dates the vial was initially stored in the refrigerator*: the same date that the dose was administered (17-May-2022).; expired doses administered to 8 patients; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired doses administered to 8 patients) and PRODUCT STORAGE ERROR (Vail was expired on 29Apr2022 and Dates the vial was initially stored in the refrigerator*: the same date that the dose was administered (17-May-2022).) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 17-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired doses administered to 8 patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vail was expired on 29Apr2022 and Dates the vial was initially stored in the refrigerator*: the same date that the dose was administered (17-May-2022).). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired doses administered to 8 patients) and PRODUCT STORAGE ERROR (Vail was expired on 29Apr2022 and Dates the vial was initially stored in the refrigerator*: the same date that the dose was administered (17-May-2022).) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The primary series of the patient may have been Moderna but there was no documentation available. No concomitant medications were reported. The vial was initially stored in the refrigerator at the same date that the dose was administered. The vial did not undergo any temperature excursions. Treatment Not provided.
This report described the occurrence of joint swelling in a female patient who received Lyme disease vaccine recombinant for prophylaxis. This report was received as part of litigation proceedings, and has not been verified by a physician or other health care professional. The patient received an unspecified number of injections of Lymerix between 1998 and 2000 with the last dose in May of 2000 according to the client. On 9/3/03, the patient's attorney alleged that the patient suffered swelling of her elbow, thumbs, and knees since 2000. Time to onset from immunization, treatment, and outcomes of the alleged events were not reported.
Approximately five hours after my moderna booster I started feeling odd. I was starting to feel cold but in a way that, due to a prior reaction to medication (serzone), I knew wasn't normal. My skin felt as though it was tingling and crawling but inside my body it felt as if my internal organs, blood etc. were frozen solid. I also had chest pains and my heart felt "sore" in a brain freeze type way. It's difficult to articulate but that's the best way I can describe it. Overall, I just didn't feel right. It continued until approximately 10:00 p.m. I self treated via warm shower, heating pad, bundling up and drinking a lot of water.
Day after receiving vaccine in (R) deltoid, pt developed itchy rash in neck area ant and post.
Initial unsolicited report received from a nurse on 10-May-2017. This case involves 64-year-old female patient, while administering dose of ADACEL (Batch number: U5604AA, expiration date-17-Mar-2019) dose, dose in series, route and site of administration were not reported) on 10-May-2017 finger got lacerated. It was also reported that report filed on Amerisource Bergen account. Medical history was reported that pre-existing physician diagnosed allergies, birth defects, medical conditions (specify) was unknown. Illness at the time of vaccination was unknown. Any other vaccinations within four weeks of vaccinations were not reported. On 10-May-2017, during administration of vaccine the index and middle finger on the left hand were lacerated. Both lacerations were 0.25 inch in length and the other is less than 0.25 inch. It was also a case of syringe issue as during the vaccination 2 flanges on the side of the syringe broke off and the glass cut her fingers. Laboratory investigations and corrective treatment were not reported. Outcome of the event was not resolved. Documents held by sender: none.
Patient was exposed to a sibling that had chickenpox ~10 days earlier. Patient has ~20 red bumps that blistered : later scabbed.
Temperature of 99.4 from 7:30am-12pm, redness and warmth around injection area, pale skin, and  irritable.
heart condition; This is a spontaneous report from a contactable consumer. An elderly male patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation. The patient had pre- existing conditions. The patient's concomitant medications were not reported. The patient experienced heart condition and died. It was not reported if an autopsy was performed.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.; Reported Cause(s) of Death: heart condition
Injection site is red and swollen since 9/23/22 when she recieved the vaccine
Pt has significant local reaction indicated by redness, swelling and fever at injection site. Swelling, redness measurement is 7.5 X 8 inches on arm. Pt states pressure with coolness "feels good". 3rd Anthrax shots in series.
Arm is very painful, it also hurt for the first dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm is very painful, it also hurt for the first dose) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939906 and 034F21A) for COVID-19 vaccination.     The patient's past medical history included Stomach ache (Had reflux and felt like a ball in the stomach).   On 09-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm is very painful, it also hurt for the first dose). At the time of the report, VACCINATION SITE PAIN (Arm is very painful, it also hurt for the first dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medications were not reported.  No treatment information was provided.   This case was linked to MOD-2021-383028 (Patient Link).
Redness, swelling and warmth to the left thigh small skin bulla at center of redness. Mom first noticed the morning of 3-28-18. Mom brought child in for an office visit the afternoon of 3-28-18. Doctor started pt. on cephalexin and advised Mom to give diphenhydramine as directed.
patient is late for the second dose / first dose was administrated on 2018; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix with an associated reaction of no adverse event (1st dose received in 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The case was reported by Office manager  The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive the 2nd dose of the Shingrix, which led to incomplete course of vaccination. The reporter did not consented to follow up. No further information was reported.
at 2:40 pm - 10 minutes after receiving vaccine, pt reports nausea and dizzy. 2:47 pm pt drinking water, reports feeling better, declines BP check or evaluation by EMS 2:55 pm BP 17/107 P 74 pt reports feeling better, she reports has history of uncontrolled HTN 3:00 pm BP 163/ 93, P 64 3:10 pm BP 142/87 P 64 pt reports feels fine and would like to go home
My last period was October 2021  just one month after my second dose of the Covid vaccine. I?ve also developed huge lymph nodes in my neck and am constantly exhausted. I have trouble breathing. I wake up pouring sweat. I could sleep for days. My sons have not missed a day of school until this year. So far they have missed 11 days and it?s 100% because I literally cannot get out of bed. Thanks to you and the government forcing me to get vaccinated, I?m now being tested for cancer.
MILD HANGOVER LIKE SYMPTOMS; SLIGHT FEVER; This spontaneous report received from a patient via a company representative concerned an adult male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced mild hangover like symptoms, and slight fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from mild hangover like symptoms, and slight fever. This report was non-serious.
Papular erythemic lesions; some vessicles some scabbed less than 10 lesions total onset about 3 days ago; no pruritis; low grade fever, 07/01/2005.
Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Patient suspected injection site infection-Medium, Additional Details: Patient described upper arm pain radiates to shoulder since vaccine was administered and not relieved with warm compress/otc ibuprofen. She also stated that the injection site was infected (no visible swelling/discharge/oozing at the site, only small dried scab). Patient requested pharmacy to dispense oral antibiotic for the wound. We recommended to continue applying otc topical antibiotic and contact pcp for further evaluation of the pain.
tested positive for covid 19; This is a spontaneous report received from a  non-contactable consumer (patient herself) via medical information team..A female patient of an unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), dose 1 via an unspecified route of administration on 12Mar2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient had the first dose of PFIZER-BIONTECH COVID-19 VACCINE on 12MAR2021 and on 16MAR2021, she tested positive for COVID-19.  Patient was told it was ok for her to get the second dose but she wanted to make sure. She also said that she felt great compared to what she did before, she completed the 14 days quarantine and she will be taking the COVID test tomorrow or Friday from the time of report. The outcome of the event was unknown.   Information on the lot/batch number has been requested.
This is a spontaneous report from a contactable consumer. A 18-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), via intramuscular, administered in arm right on 17Apr2021 at 11:15 (age at vaccination 18-years-old, non-pregnant) (Batch/Lot Number: EP6955) as DOSE 2, SINGLE and dose 1 intramuscular, administered in arm left on 29Mar2021 at 10:45 (Batch/Lot Number: EP6955) as DOSE 1, SINGLE for covid-19 immunization. Medical history included migraine from an unknown date and unknown if ongoing. There were no concomitant medications. Facility where the recent COVID-19 vaccine was administered was clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 25Jul2021, patient experienced COVID-19. It was reported patient tested positive for Covid-19, results received 04Aug21. Patient did not receive any treatment for the events. The events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included PCR/ nasal swab on 03Aug2021 which was positive (results received on 04Aug21). The outcome of the events was recovering.  Follow-up attempts are completed. No further information is expected.
sore arm; A spontaneous report was received from a consumer concerning a 72-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events sore arm.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 10 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 041L20A) via unknown route in the left arm for prophylaxis of COVID-19 infection.  On 10 Feb 2021, the patient experienced the event(s) sore arm.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), sore arm was unknown.
Fever, body aches, chills, congestion,cough, head ache, nausea, exhaustion
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On 05-JUL-2012 the patient was vaccinated with a dose of ZOSTAVAX that was stored at 21.6F for 25 days (600 hours). It was unknown if the patient sought medical attention. The patient was not experiencing any known symptoms. This is one of several reports received from the same source. Additional information has been requested.
Pt states that bilateral arms broke out in a raised rash starting approximately 1.5 hours after receiving vaccine.
Swelling of Tricep from shoulder to elbow, warm, erythema, swelling.  Fevers to 102 for 12 hours the 100 for 24.